UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
MSD to check on maintenance of ovarian cancer drug Lynparza
The Ministry of Food and Drug Safety approved MSD Korea to conduct a phase-...
by Lee Hye-seon
|
2018-11-14 14:06
라인
Half of cosmetics claiming anti-fine dust effect falsely advertised
Half of the cosmetic products that claimed to block the skin from fine dust...
by Lee Hye-seon
|
2018-11-14 11:54
라인
Korea recalls BCG vaccines from Japan due to excessive arsenic
The Ministry of Food and Drug Safety said it would recall the entire batch ...
by Lee Hye-seon
|
2018-11-08 15:42
라인
Well Marker Bio raises ₩28 billion for anticancer drug development
Anticancer treatment developer Well Marker Bio said it has completed the so...
by Lee Hye-seon
|
2018-11-08 15:10
라인
CJ HealthCare aims to add indication for Helicobacter eradication
CJ HealthCare is seeking to add an indication for the eradication of Helico...
by Lee Hye-seon
|
2018-11-07 14:58
라인
LG Chem to work on bilayer tablet for diabetes, dyslipidemia
LG Chem said it would start developing bilayer tablets of Zemiro (gemiglipt...
by Lee Hye-seon
|
2018-11-06 11:06
라인
Cornea implant device recalled due to risk of corneal haze
The Ministry of Food and Drug Safety ordered a recall of “Raindrop Near Vis...
by Lee Hye-seon
|
2018-10-31 11:28
라인
‘Physicians need more discretion to use biologic drugs for psoriasis’
The government should amend the healthcare system to use more biologic medi...
by Lee Hye-seon
|
2018-10-29 16:50
라인
Ministry OKs phase-3a clinical trial for new anti-diabetes drug
Novo Nordisk said it would conduct phase 3a clinical trial for Ozempic in K...
by Lee Hye-seon
|
2018-10-26 14:18
라인
Ono Pharma Korea rebuked for late reporting of adverse events
The Ministry of Food and Drug Safety issued a warning to Ono Pharma Korea f...
by Lee Hye-seon
|
2018-10-25 13:55
라인
Daewoong wins nod for phase-3 study on new antiulcer drug
Daewoong Pharmaceutical said it obtained regulatory approval to conduct a p...
by Lee Hye-seon
|
2018-10-24 15:15
라인
Listed pharmaceuticals’ operating margins decline to 12.2 pct. in H1
The operating profit to sales ratio of 110 pharmaceutical companies listed ...
by Lee Hye-seon
|
2018-10-19 14:20
라인
Lawmakers rebuke poor follow-up steps of hypertension drug recall
Members of the National Assembly’s Health and Welfare Committee criticized ...
by Lee Hye-seon
|
2018-10-16 12:07
라인
BMS to test cabiralizumab+nivolumab for pancreatic cancer
Bristol-Myers Squibb is soon to conduct phase-2 trials in Korea on its immu...
by Lee Hye-seon
|
2018-10-11 14:23
라인
Abbott’s hepatitis B antibody reagent recalled due to error
The government ordered Korea Abbott to recall its hepatitis B antibody reag...
by Lee Hye-seon
|
2018-10-08 15:52
라인
Amantadine sulfate to lose indication for influenza A virus treatment
The government said it would change approval conditions for two pharmaceuti...
by Lee Hye-seon
|
2018-10-08 15:49
라인
Allergan’s eye implant recalled due to foreign substance
Allergan is recalling Ozurdex Intravitreal Implant 700㎍ (ingredient: dexame...
by Lee Hye-seon
|
2018-10-05 13:53
라인
BMS to start phase-3 test on oral psoriasis treatment in Korea
Bristol-Myers Squibb said it would begin global phase-3 trials on BMS-98616...
by Lee Hye-seon
|
2018-10-01 15:09
라인
Dong-A ST ordered to suspend sale of 12 drugs due to illegal rebates
The Ministry of Food and Drug Safety said it has ordered Dong-A ST to suspe...
by Lee Hye-seon
|
2018-09-27 15:33
라인
Severance, Asan violate clinical trial protocol
The Severance Hospital in Sinchon, Seoul, and Yongin Severance Hospital in ...
by Lee Hye-seon
|
2018-09-20 11:31
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top